首页> 外文期刊>Journal of Environmental Science and Health. A >Area under the blood concentration-time curve (AUC) of ethylbenzene concentration in rats: relationship to inhalation and oral administration route-dose
【24h】

Area under the blood concentration-time curve (AUC) of ethylbenzene concentration in rats: relationship to inhalation and oral administration route-dose

机译:大鼠乙苯浓度血液浓度 - 时间曲线(AUC)下的区域:吸入和口服给药的关系

获取原文
获取原文并翻译 | 示例
       

摘要

For human risk assessment of toxic chemicals, especially volatile organic compounds (VOCs), the Ministry of the Environment, Government of Japan, has called for the interconversion of inhalation-dose and oral-dose data, two common exposure routes. To address this issue, the present study investigated the time-course changes of ethylbenzene (EB) concentrations in the blood of rats during and after 6-hr inhalation exposure to EB (25, 50, 100, and 200 ppm) and after oral administration of EB by a single oral gavage (25, 50, 100, and 200 mg/kg) of EB. The Area Under the blood concentration-time Curve (AUC) at each blood collection time point (0, 30, 60, 120, 180, 360, 420, 540, and 1440 min, after starting exposure) was determined. The inhalation dose of 25 ppm corresponded closely to the oral administration of 25 mg/kgbw (r value of 0.859), and the inhalation dose of 200 ppm correlated with the oral administration of 100 mg/kgbw (r value of 0.948). These results suggest that this comparison using the AUC data at each blood collection time point is valuable for understanding the route- and dose-effects of EB. This study will improve risk assessment of human exposure to EB and other VOCs.
机译:对于人体风险评估有毒化学品,特别是挥发性有机化合物(VOC),日本政府,环境政府,已呼吁吸入剂量和口服剂量数据,两个常见的暴露途径。为了解决这个问题,本研究研究了在6小时吸入暴露于EB(25,50,100和200ppm)和口服给药后大鼠血液中乙苯(EB)浓度的时间过程变化EB通过单一的口服饲养(25,50,100和200mg / kg)EB。确定在每个血液收集时间点(0,30,60,120,180,360,420,540,360,420,540,360,420,540,360,420,540和1440min的血液浓度 - 时间曲线(AUC)的区域。 25ppm的吸入剂量与25mg / kgbw(R值为0.859)的口服给药相对应,与200ppm的吸入剂量与100mg / kgbw的口服给药(R值为0.948)相关。这些结果表明,使用每个血液收集时间点的AUC数据的这种比较对于理解EB的途径和剂量效应是有价值的。本研究将改善人类暴露于EB和其他VOC的风险评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号